Botanix Pharmaceuticals Ltd (BOT) — Long-term Investment Intensity
Botanix Pharmaceuticals Ltd (BOT) has a Long-term Investment Intensity of 0.4% as of June 2022. Long-term investments of AU$61.71K represent 0.4% of total assets of AU$14.04 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See BOT net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Botanix Pharmaceuticals Ltd Long-term Investment Intensity (2020–2022)
This chart shows how Botanix Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2020 to 2022. As of June 2022, the intensity stands at 0.4%, reflecting long-term investments of AU$61.71K against total assets of AU$14.04 Million AUD. Also explore BOT current and non-current assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Botanix Pharmaceuticals Ltd (2020–2022)
The table below presents the year-by-year Long-term Investment Intensity for Botanix Pharmaceuticals Ltd from 2020 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Botanix Pharmaceuticals Ltd market cap and net worth.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 0.4% | AU$61.71K | AU$14.04 Million | ▲ +0.2 pp |
| 2021 | 0.3% | AU$62.37K | AU$21.95 Million | ▼ -0.1 pp |
| 2020 | 0.4% | AU$88.73K | AU$25.31 Million | — |